You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 1, January 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Major Salivary Gland Carcinoma

Descriptive Epidemiology and Survival of 498 Patients

Margaret R. Spitz, MD, MPH; John G. Batsakis, MD

Arch Otolaryngol. 1984;110(1):45-49.


Abstract

• A retrospective chart review study was conducted on 498 patients with histopathologically confirmed carcinoma of the major salivary glands to ascertain the potential risk factors and to abstract the clinicopathologic and survival data. The distribution of histologic classification varied by race, sex, and history of benign salivary gland lesion (37 patients). Of the 57 patients who had a history of radiation exposure, 49 patients had been irradiated in a field encompassing the salivary gland area. Sixty-six patients had had a prior primary cancer. Of 43 instances of previous skin cancer, 37 occurred in male patients. The rationale for a possible relationship between cutaneous neoplasms and salivary carcinoma is explained embryologically and histogenetically. Tumor histology, anatomic site, race, and sex were important predictors of survival.

(Arch Otolaryngol 1984;110:45-49)



Author Affiliations

From the Departments of Cancer Prevention (Dr Spitz), and Pathology (Dr Batsakis), University of Texas M. D. Anderson Hospital and Tumor Institute, Houston.


Footnotes

Accepted for publication July 20, 1983.

Reprint requests to the University of Texas M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Ave, Houston, TX 77030 (Dr Spitz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incidence of Carcinoma of the Major Salivary Glands According to the WHO Classification, 1992 to 2006: A Population-Based Study in the United States
Boukheris et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2899-2906.
ABSTRACT | FULL TEXT  

Mucoepidermoid carcinoma of the parotid gland in children: A 10-year experience.
Rahbar et al.
Arch Otolaryngol Head Neck Surg 2006;132:375-380.
ABSTRACT | FULL TEXT  

Mucoepidermoid Carcinoma of the Parotid Gland: The Mayo Clinic Experience
Boahene et al.
Arch Otolaryngol Head Neck Surg 2004;130:849-856.
ABSTRACT | FULL TEXT  

Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour
Etges et al.
J. Clin. Pathol. 2003;56:914-918.
ABSTRACT | FULL TEXT  

Nodal Metastasis in Major Salivary Gland Cancer: Predictive Factors and Effects on Survival
Bhattacharyya and Fried
Arch Otolaryngol Head Neck Surg 2002;128:904-908.
ABSTRACT | FULL TEXT  

Estrogen Receptors in Normal Salivary Gland and Salivary Gland Carcinoma
Dimery et al.
Arch Otolaryngol Head Neck Surg 1987;113:1082-1085.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.